Current Management of Thyroid Eye Disease-Reference-Cited by-同舟云学术

Current Management of Thyroid Eye Disease

Published:2021-06-11 Issue:7 Volume:23 Page:
ISSN:1092-8480
Container-title:Current Treatment Options in Neurology
language:en
Short-container-title:Curr Treat Options Neurol

Author:

Mahoney Nicholas R.^ORCID,Rajaii Fatemeh

Funder

National Eye Institute

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical)

Link

https://link.springer.com/content/pdf/10.1007/s11940-021-00675-3.pdf

Reference94 articles.

1. Bahn RS. Graves’ ophthalmopathy. N Engl J Med. 2010;362:726–38.

2. Bartley GB. The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Trans Am Ophthalmol Soc. 1994;92:477–588.

3. Chin YH, Ng CH, Lee MH, Koh JWH, Kiew J, Yang SP, et al. Prevalence of thyroid eye disease in Graves’ disease: a meta-analysis and systematic review. Clin Endocrinol. 2020;93:363–74. https://doi.org/10.1111/cen.14296.

4. Nunery WR. Michael J. Hawes Lecture: Observations after forty years of managing thyroid eye disease – the importance of subtypes. Presented at: American Society of Ophthalmic Plastic and Reconstructive Surgery meeting; Oct. 10–11, 2019; San Francisco.

5. Choudhary MM, Zhang KR, Johnson S, Hwang CJ, Chon BH, Perry JD. Temporal fat pad volume in patients with thyroid eye disease. Ophthalmic Plast Reconstr Surg. 2020;36:194–7.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical features, pathophysiology, and management of thyroid eye disease;Minerva Ophthalmology;2023-12